Celltrion “Mutation treatment in South Africa, clinical completion within 6 months”

Input 2021.02.11 16:56 | Revision 2021.02.11 16:57

Celltrion (068270)Announced on the 11th that it will also develop a mutant coronavirus treatment in South Africa.-

–

Celltrion said, “With the aim of completing clinical trials within 6 months, we plan to develop a therapeutic agent before the South African mutant virus continues to spread and becomes a new dominant (most common type) virus, as soon as possible.”

The Central Defense Response Headquarters said on the day that Celltrion’s corona antibody treatment,’Reckirona’, showed excellent neutralizing ability against the existing 6 coronaviruses and the UK mutant virus, but it was not effective against the South African mutant virus.

Celltrion also explained, “By using the cocktail method, we have established a platform that can quickly respond to mutant viruses that may occur sporadically in the future as well as mutant viruses currently appearing around the world, such as mutant viruses in the UK, South Africa and Brazil.”

“In particular, the technology of the PCR diagnostic kit has taken a leap to the level of diagnosing mutant viruses,” he said. “By actively utilizing this, even if additional mutations occur, we can quickly respond by selecting suitable antibodies on our own platform.”

–

– .

Related posts:

Labor Minister proclaims monetary grants for irregular employees in a number of circumstances - Misr...

Security Forces Capture Dangerous Criminals and Seize Weapons in Assiut Incident

Telework: unions are studying the employers' text, which remains non-binding

Russian soldiers at the border, attack on Izyum